The groundbreaking treatment of the medication represents a significant development in the care of the condition. Distinct from existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide466584.webbuzzfeed.com/42429176/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment